|TEV||31||TEV/EBIT||8||TTM 2019-09-30, in MM, except price, ratios|
|Item 5.07. Submission of Matters To A Vote of Security Holders|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 18, 2018
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
|(State or Other Jurisdiction |
|(Commission File Number)||I.R.S. Employer|
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders
Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 18, 2018. The proposals submitted by the Board of Directors to a vote of the shareholders, and the results of the voting on each proposal, are noted below.
Proposal No. 1 — Election of Directors.
The following nominees were elected by the shareholders to serve on the Company’s Board of Directors until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified:
|Jeffrey S. Barocas||6,621,606||307,941||2,263,031|
|Diana Mazuelos Conard||6,857,741||71,806||2,263,031|
|Gregor M. Dornau||6,671,074||258,473||2,263,031|
|Peter G. Dornau||6,671,074||258,473||2,263,031|
|William W. Dudman||6,671,074||258,473||2,263,031|
|James M. Kolisch||6,661,071||268,473||2,263,031|
|Kimberly A. Krause||6,867,741||61,806||2,263,031|
|John B. Turner||6,857,491||72,056||2,263,031|
Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.
The shareholders ratified the appointment of Accell Audit & Compliance, PA as the Company's independent registered public accounting firm for 2018. The voting results were as follows:
Proposal No. 3 — Advisory Vote on the Compensation of our Named Executive Officers;
The shareholders approved, on an advisory basis, the compensation of our named executive officers. The voting results were as follows.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|OCEAN BIO-CHEM, INC.|
|Date: May 23, 2018||By:||/s/ Jeffrey S. Barocas|
|Jeffrey S. Barocas|
|Chief Financial Officer|